US Patent Issued to Enzyvant Therapeutics, Duke University on July 22 for "Methods of determining the suitability of cultured thymus tissue for implantation into humans and associated methods of use" (North Carolina, Massachusetts Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,715, issued on July 22, was assigned to Enzyvant Therapeutics GMBH (Basel, Switzerland) and Duke University (Durham, N.C.).

"Methods of determining the suitability of cultured thymus tissue for implantation into humans and associated methods of use" was invented by Mary Louise Markert (Durham, N.C.), Laura P. Hale (Durham, N.C.), Joanne Kurtzberg (Durham, N.C.), Lynn Cheatham (Durham, N.C.), Gregory D. Sempowski (Durham, N.C.), Andrew N. MacIntyre (Durham, N.C.), Alex Tracy (Cambridge, Mass.), Kristin Marks (Cambridge, Mass.) and Karin Pihel (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for promoting donor...